{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:47Z","timestamp":1793813987532,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Open Research Projects of the Ministry of Education Innovation Center for Basic Medical Research on Metabolic Cardiovascular Diseases","award":["Grant Nos. xnykdxcxzx-2024-13"],"award-info":[{"award-number":["Grant Nos. xnykdxcxzx-2024-13"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant Nos. U23A20398\uff0cGrant Nos. 82030007"],"award-info":[{"award-number":["Grant Nos. U23A20398\uff0cGrant Nos. 82030007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["Grant Nos. 2024ZD0537707"],"award-info":[{"award-number":["Grant Nos. 2024ZD0537707"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04715-6","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:52:44Z","timestamp":1761745964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Empagliflozin-pretreated BMSC exosomes attenuate myocardial ischemia-reperfusion injury by enhancing atad3a\/pink1-dependent mitophagy"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuling","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"4715_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","volume":"75","author":"P Ferdinandy","year":"2023","unstructured":"Ferdinandy P, Andreadou I, Baxter GF, B\u00f8tker HE, Davidson SM, Dobrev D, Gersh BJ, Heusch G, Lecour S, Ruiz-Meana M, Zuurbier CJ, Hausenloy DJ, Schulz R. Interaction of cardiovascular nonmodifiable risk Factors, comorbidities and comedications with Ischemia\/Reperfusion injury and cardioprotection by Pharmacological treatments and ischemic conditioning. Pharmacol Rev. 2023;75(1):159\u2013216.","journal-title":"Pharmacol Rev"},{"key":"4715_CR2","doi-asserted-by":"publisher","unstructured":"Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells. 2021;10(8):1959. https:\/\/doi.org\/10.3390\/cells10081959.","DOI":"10.3390\/cells10081959"},{"issue":"8","key":"4715_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cells8080784","volume":"8","author":"X Fu","year":"2019","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784. https:\/\/doi.org\/10.3390\/cells8080784.","journal-title":"Cells"},{"key":"4715_CR4","doi-asserted-by":"publisher","unstructured":"Peng Y, Zhao JL, Peng ZY, Xu WF, Yu GL. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 2020;11(5):317. https:\/\/doi.org\/10.1038\/s41419-020-2545-6. Erratum in: Cell Death Dis. 2020;11(9):791. doi: 10.1038\/s41419-020-02996-8. Erratum in: Cell Death Dis. 2020;11(10):845. doi: 10.1038\/s41419-020-03025-4.","DOI":"10.1038\/s41419-020-2545-6"},{"key":"4715_CR5","doi-asserted-by":"publisher","unstructured":"Xiao C, Wang K, Xu Y, Hu H, Zhang N, Wang Y, Zhong Z, Zhao J, Li Q, Zhu D, Ke C, Zhong S, Wu X, Yu H, Zhu W, Chen J, Zhang J, Wang J, Hu X. Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b. Circ Res. 2018;123(5):564\u2013578. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312758.","DOI":"10.1161\/CIRCRESAHA.118.312758"},{"issue":"7","key":"4715_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","volume":"115","author":"J Zhao","year":"2019","unstructured":"Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, Gao L, Xie J, Xu B. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvz040.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4715_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Shen H, Shao L, Teng X, Chen Y, Liu X, Yang Z, Shen Z. HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther. 2020;11(1):373. https:\/\/doi.org\/10.1186\/s13287-020-01881-7.","journal-title":"Stem Cell Res Ther"},{"key":"4715_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2023.04.014","volume":"358","author":"S Li","year":"2023","unstructured":"Li S, Yang K, Cao W, Guo R, Liu Z, Zhang J, Fan A, Huang Y, Ma C, Li L, Fan G. Tanshinone IIA enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in myocardial ischemia\/reperfusion injury via up-regulating miR-223-5p. J Control Release. 2023;358:13\u201326.","journal-title":"J Control Release"},{"issue":"2","key":"4715_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvz139","volume":"116","author":"P Huang","year":"2020","unstructured":"Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L, Yang Y. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353\u201367. https:\/\/doi.org\/10.1093\/cvr\/cvz139.","journal-title":"Cardiovasc Res"},{"issue":"16","key":"4715_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pi\u00f1a IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M. EMPEROR-Preserved trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038.","journal-title":"N Engl J Med"},{"key":"4715_CR11","doi-asserted-by":"publisher","unstructured":"Cai C, Guo Z, Chang X, Li Z, Wu F, He J, Cao T, Wang K, Shi N, Zhou H, Toan S, Muid D, Tan Y. Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPK\u03b11\/ULK1\/FUNDC1\/mitophagy pathway. Redox Biol. 2022;52:102288. doi: 10.1016\/j.redox.2022.102288. Epub 2022 Mar 18. Erratum in: Redox Biol. 2023;63:102738. https:\/\/doi.org\/10.1016\/j.redox.2023.102738.","DOI":"10.1016\/j.redox.2023.102738"},{"issue":"1","key":"4715_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-020-01127-z","volume":"19","author":"W Shimizu","year":"2020","unstructured":"Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, Yodogawa K, Iwasaki YK, Yamamoto T, Takano H, Tsukada Y, Asai K, Miyamoto M, Miyauchi Y, Kodani E, Ishikawa M, Maruyama M, Ogano M, Tanabe J. EMBODY trial investigators. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovasc Diabetol. 2020;19(1):148. https:\/\/doi.org\/10.1186\/s12933-020-01127-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"4715_CR13","doi-asserted-by":"publisher","first-page":"100613","DOI":"10.1016\/j.bj.2023.100613","volume":"47","author":"CC Yang","year":"2024","unstructured":"Yang CC, Chen YL, Sung PH, Chiang JY, Chen CH, Li YC, Yip HK. Repeated administration of adipose-derived mesenchymal stem cells added on beneficial effects of empagliflozin on protecting renal function in diabetic kidney disease rat. Biomed J. 2024;47(2):100613. https:\/\/doi.org\/10.1016\/j.bj.2023.100613.","journal-title":"Biomed J"},{"key":"4715_CR14","doi-asserted-by":"publisher","first-page":"7747727","DOI":"10.1155\/2023\/7747727","volume":"2023","author":"B Chi","year":"2023","unstructured":"Chi B, Zou A, Mao L, Cai D, Xiao T, Wang Y, Wang Q, Ji Y, Sun L. Empagliflozin-Pretreated mesenchymal stem Cell-Derived small extracellular vesicles attenuated heart injury. Oxid Med Cell Longev. 2023;2023:7747727. https:\/\/doi.org\/10.1155\/2023\/7747727.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4715_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"XQ Xie","year":"2023","unstructured":"Xie XQ, Yang Y, Wang Q, Liu HF, Fang XY, Li CL, Jiang YZ, Wang S, Zhao HY, Miao JY, Ding SS, Liu XD, Yao XH, Yang WT, Jiang J, Shao ZM, Jin G, Bian XW. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33(3):215\u201328. https:\/\/doi.org\/10.1038\/s41422-022-00766-z.","journal-title":"Cell Res"},{"key":"4715_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.freeradbiomed.2024.09.029","volume":"224","author":"X Li","year":"2024","unstructured":"Li X, Guan L, Liu Z, Du Z, Yuan Q, Zhou F, Yang X, Lv M, Lv L. Ubiquitination of ATAD3A by TRIM25 exacerbates cerebral ischemia-reperfusion injury via regulating PINK1\/Parkin signaling pathway-mediated mitophagy. Free Radic Biol Med. 2024;224:757\u201369.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"4715_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-020-01768-8","volume":"39","author":"H Wu","year":"2020","unstructured":"Wu H, Wang T, Liu Y, Li X, Xu S, Wu C, Zou H, Cao M, Jin G, Lang J, Wang B, Liu B, Luo X, Xu C. Mitophagy promotes Sorafenib resistance through hypoxia-inducible ATAD3A dependent axis. J Exp Clin Cancer Res. 2020;39(1):274. https:\/\/doi.org\/10.1186\/s13046-020-01768-8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"4715_CR18","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.jbc.2022.102008","volume":"298","author":"L Chen","year":"2022","unstructured":"Chen L, Li Y, Sottas C, et al. Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria [J]. J Biol Chem. 2022;298(6):102008. https:\/\/doi.org\/10.1016\/j.jbc.2022.102008.","journal-title":"J Biol Chem"},{"issue":"16","key":"4715_CR19","doi-asserted-by":"publisher","first-page":"e165568","DOI":"10.1172\/jci.insight.165568","volume":"8","author":"Y Yu","year":"2023","unstructured":"Yu Y, Yang H, Li Q, Ding N, Gao J, Qiao G, Feng J, Zhang X, Wu J, Yu Y, Zhou X, Wang X, Zhang C. Stress-enhanced cardiac LncRNA morrbid protects hearts from acute myocardial infarction. JCI Insight. 2023;8(16):e165568. https:\/\/doi.org\/10.1172\/jci.insight.165568.","journal-title":"JCI Insight"},{"key":"4715_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2019.02.002","volume":"177","author":"XH Sun","year":"2019","unstructured":"Sun XH, Wang X, Zhang Y, et al. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN\/PI3K\/AKT signaling pathway [J]. Thromb Res. 2019;177:23\u201332.","journal-title":"Thromb Res"},{"issue":"8","key":"4715_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1253\/circj.CJ-19-1060","volume":"84","author":"T Li","year":"2020","unstructured":"Li T, Gu J, Yang O, Wang J, Wang Y, Kong J. Bone marrow mesenchymal stem Cell-Derived Exosomal miRNA-29c decreases cardiac Ischemia\/Reperfusion injury through Inhibition of excessive autophagy via the PTEN\/Akt\/mTOR signaling pathway. Circ J. 2020;84(8):1304\u201311. https:\/\/doi.org\/10.1253\/circj.CJ-19-1060.","journal-title":"Circ J"},{"issue":"1","key":"4715_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41420-022-00909-6","volume":"8","author":"R Yue","year":"2022","unstructured":"Yue R, Lu S, Luo Y, Zeng J, Liang H, Qin D, Wang X, Wang T, Pu J, Hu H. Mesenchymal stem cell-derived Exosomal microRNA-182-5p alleviates myocardial ischemia\/reperfusion injury by targeting GSDMD in mice. Cell Death Discov. 2022;8(1):202. https:\/\/doi.org\/10.1038\/s41420-022-00909-6.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4715_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10565-020-09530-8","volume":"37","author":"Y Song","year":"2021","unstructured":"Song Y, Wang B, Zhu X, Hu J, Sun J, Xuan J, Ge Z. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol. 2021;37(1):51\u201364. https:\/\/doi.org\/10.1007\/s10565-020-09530-8.","journal-title":"Cell Biol Toxicol"},{"issue":"5","key":"4715_CR24","doi-asserted-by":"publisher","first-page":"H1341","DOI":"10.1152\/ajpheart.00028.2018","volume":"315","author":"G Paradies","year":"2018","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Mitochondrial bioenergetics and Cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for Pharmacological cardioprotection. Am J Physiol Heart Circ Physiol. 2018;315(5):H1341\u201352. https:\/\/doi.org\/10.1152\/ajpheart.00028.2018.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4715_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.actbio.2024.07.059","volume":"186","author":"X Zhu","year":"2024","unstructured":"Zhu X, Liu Q, Zhu F, Jiang R, Lu Z, Wang C, Gong P, Yao Q, Xia T, Sun J, Ju F, Wang D, Sun R, Zhou Y, You B, Shi W. An engineered cellular carrier delivers miR-138-5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A\/Rhebl1 axis. Acta Biomater. 2024;186:424\u201338.","journal-title":"Acta Biomater"},{"issue":"8","key":"4715_CR26","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1111\/cns.14159","volume":"29","author":"L Zhang","year":"2023","unstructured":"Zhang L, Lin Y, Bai W, Sun L, Tian M. Human umbilical cord mesenchymal stem cell-derived exosome suppresses programmed cell death in traumatic brain injury via PINK1\/Parkin-mediated mitophagy. CNS Neurosci Ther. 2023;29(8):2236\u201358. https:\/\/doi.org\/10.1111\/cns.14159.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4715_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-021-00808-5","volume":"19","author":"W Zhu","year":"2021","unstructured":"Zhu W, Sun L, Zhao P, Liu Y, Zhang J, Zhang Y, Hong Y, Zhu Y, Lu Y, Zhao W, Chen X, Zhang F. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p. J Nanobiotechnol. 2021;19(1):61. https:\/\/doi.org\/10.1186\/s12951-021-00808-5.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4715_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s13287-022-02984-z","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Lu Y, Mao Y, Yu Y, Wu T, Zhao W, Zhu Y, Zhao P, Zhang F. IFN-\u03b3 enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats. Stem Cell Res Ther. 2022;13(1):333. https:\/\/doi.org\/10.1186\/s13287-022-02984-z.","journal-title":"Stem Cell Res Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04715-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:52:45Z","timestamp":1761745965000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04715-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04715-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures conformed to Guide for Care and Use of Laboratory Animals published by US National Institute of Health (8th edition, 2011) and were approved by the Institutional Animal Care and Treatment Committee of Southwest Medical University, China.Consent for publication.Title of the approved project: Exosome in myocardial cell injury and ischemic heart disease. The ethical number is No. 2020255.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}